Mizoribine is a newly developed immunosuppressive agent with few toxic effects.1 The pharmacologic effects of mizoribine are similar to those of another purine biosynthesis inhibitor, mycophenolate mofetil. Published studies have shown positive effects of mizoribine and a favorable safety profile for its use in treating nephrotic syndrome,2 IgA nephropathy,3 and lupus nephritis.1